Méhnyakrák: vizsgálatok itt: Kína
135 of 159 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Chengdu, Guangzhou
- Életkor
- 18 év and over
- People
- 890 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 3. fázisNot yet taking people in KínaQL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 486
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT07613567 - No phaseTaking peopleThe Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)
- Where
- Chongqing
- Életkor
- 18 év to 70 év
- People
- 452
- Run by
- Chongqing University Cancer Hospital
See details and how to joinNCT04555226 - 2. fázisTaking peopleAutologous Tumor Infiltrating Lymphocytes Injection (GT101 Injection) for the Treatment of Recurrent or Metastatic Cervical Cancer
- Where
- Beijing, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Guilin, Ha’erbin, Hangzhou, Jinan, Jining, Kunming, Lanzhou, Luoyang, Nanchang, Nanjing, Shanghai, Shenyang, Shenzhen, Taiyuan, Tianjin, Wuhan, Xi’an, Yibin, Zhengzhou
- Életkor
- 18 év to 70 év
- People
- 100
- Run by
- Grit Biotechnology
See details and how to joinNCT06241781 - 3. fázisTaking peopleStudy of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
- Where
- Beijing, Changde, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Hangzhou, Harbin, Kunming, Lanzhou, Linyi, Luzhou, Nanchang, Shandong, Shanghai, Shenyang, Shenzhen, Tianjin, Wuhan, Xi'an, Yibin, Yinchuan, Zhengzhou, Zhuzhou
- Életkor
- 15 év and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06079671 · EU 2023-504374-38-00 - 1/2. fázisTaking peopleRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Fujian, Guangdong, Hangzhou, Henan, Hubei, Nanchang, Shanghai, Shanxi, Shengyang, Tianjin
- Életkor
- 18 év and over
- People
- 952 worldwide
- Run by
- Genmab
See details and how to joinNCT05579366 - 1. fázisTaking peopleA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- Beijing, Guangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Beijing, Changsha, Hangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - 3. fázisTaking peopleModerated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 440
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06641635 - 2. fázisTaking peopleDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Beijing, Changsha, Chengdu, Dongguan, Henan, Hubei, Shanghai, Shenyang, Wuhan, Xi'an, Xinxiang, Xuzhou
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - No phaseTaking peopleHydrogel Spacer During Definitive Radiotherapy for Cervical Cancer
- Where
- Tianjin
- Életkor
- 17 év to 75 év
- People
- 30
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07904182 - No phaseTaking peopleFeasibility of the "One-Finger Technique" for Identifying the Upper Left Ureter During Para-Aortic Lymphadenectomy
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07895212 - 1/2. fázisTaking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Baoding, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Linyi, Luoyang, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Taizhou, Tianjin, Wuhan, Xi’an, Xinxiang, Zhengzhou
- Életkor
- 18 év and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116 - 2. fázisTaking peopleIparomlimab/Tuvonralimab Combined With Nab-paclitaxel and Cisplatin as Neoadjuvant Therapy for Locally Advanced Cervical Cancer
- Where
- Xi'an
- Életkor
- 18 év to 70 év
- People
- 34
- Run by
- Xijing Hospital
See details and how to joinNCT07876154 - 2. fázisTaking peopleA Study of YL202 in Patients With Advanced Solid Tumors
- Where
- Changsha
- Életkor
- 18 év and over
- People
- 100
- Run by
- MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07202364 - 1/2. fázisTaking peoplePhase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Where
- Beijing, Fuzhou, Guangzhou, Shandong, Shanghai
- Életkor
- 18 év and over
- People
- 233 worldwide
- Run by
- Ensem Therapeutics
See details and how to joinNCT06993844 - No phaseTaking peopleStellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic Surgery
- Where
- Huai'an
- Életkor
- 18 év to 75 év
- People
- 100
- Run by
- Catherin Zhang
See details and how to joinNCT07860203 - No phaseCsak meghívásosCNCMT:a Multi-center, Prospective, Single-arm Study
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Hubei Cancer Hospital
See details and how to joinNCT06714084 - 3. fázisTaking peopleA Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 424
- Run by
- Guangzhou Gloria Biosciences Co., Ltd.
See details and how to joinNCT05798819 - No phaseTaking peopleMH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 228
- Run by
- Xiaorong Hou
See details and how to joinNCT07584161 - 2. fázisTaking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Anyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jining, Kunming, Nanchang, Nanjing, Nanning, Shandong, Shanghai, Shenyang, Tianjin, Wuhan, Wuhou District, Zhengzhou
- Életkor
- 18 év to 64 év
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - 2. fázisNot yet taking people in KínaPerioperative Adebrelimab for Locally Advanced Cervical Cancer
- Where
- Hefei
- Életkor
- 18 év to 75 év
- People
- 35
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT07811375 - No phaseTaking peopleElectroacupuncture on Postoperative Urinary Retention After Radical Surgery for Cervical Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 70 év
- People
- 208
- Run by
- Lu Chao
See details and how to joinNCT07253194 - 3. fázisNot yet taking people in KínaJSKN033 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer
- Where
- Guangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 368
- Run by
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
See details and how to joinNCT07797153 - 4. fázisTaking peopleAn Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent Radiotherapy and Chemotherapy Following Induction Therapy With Enlonstobart Plus Chemotherapy in Patients With Locally Advanced Cervical Cancer.
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 31
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07776821